Induction of angiotensin-converting enzyme by oncostatin M in human endothelial cells

Cytokine

Volumn 12, Issue 8, 2000, Pages 1253-1256

  Saijonmaa, Outi ^a   Nyman, Tuulikki ^a   Kosonen, Riikka ^a   Fyhrquist, Frej ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cell culture; Cytokines; Endothelial function; Renin angiotensin system; Signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; HERBIMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ONCOSTATIN M;

ARTICLE; BLOOD VESSEL WALL; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY;

EID: 0033858842     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0703     Document Type: Article

References (15)

1. Dzau V, Pratt R. Cardiac, vascular, and intrarenal renin-angiotensin systems in normal physiology and disease. Robertson I, Nicholls G. The Renin-Angiotensin system. 1993;42.1-42.11 Gower Medical Publishing, London, New York.
2. Diet F, Pratt R, Berry G, Momose N, Gibbons G, Dzau V. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation. 94:1996;2756-2767.
3. Ross R. Atherosclerosis - An inflammatory disease. New Engl J Med. 340:1999;115-126.
4. Gomez-Lechon M. Oncostatin M: Signal transduction and biological activity. Life Sci. 65:1999;2019-2030.
5. Modur V, Feldhaus M, Weyrich A, Jicha D, Prescott S, Zimmerman G, Mclntyre T. Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest. 100:1997;158-168.
6. Rousseau S, Houle F, Landry J, Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:1997;2169-2177.
7. Maziere C, Auclair M, Maziere J-C. Stimulation of cell-mediated low-density lipoprotein oxidative modification by oncostatin M. Biochem Biophys Res Commun. 205:1994;60-67.
8. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients - a metaanalysis of 109 treatment studies. Am J Hypertens. 5:1992;95-110.
9. yestyrosine kinase. J Immunol. 149:1992;1676-1682.
10. MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth. J Clin Invest. 92:1993;848-857.
11. Takashima S, Klagsbrun M. Inhibition of endothelial cell growth by macrophage-like U-937 cell-derived oncostatin M, leukemia inhibitory factor, and transforming growth factor β1. J Biol Chem. 271:1996;24901-24906.
12. Saijonmaa O, Fyhrquist F. Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells. Cardiovasc Res. 40:1998;206-210.
13. Watanabe K, Lam G, Keresztes R, Jaffe E. Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells. J Cell Physiol. 150:1992;433-439.
14. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G, Corvol P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA. 85:1988;9386-9390.
15. Ponte P, Ng S-Y, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acid Res. 12:1984;1687-1696.